Search research articles
Contact Us
Filters
Showing results (121-130 of 175) with videos related to
Page
of 18
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 22, 2007
Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine
Michael Zhuo Wang, Judy Qiju Wu, Arlene S Bridges, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
From discovery to translation: Endogenous substrates of OAT1 and OAT3 as clinical biomarkers for renal secretory function
Aarzoo Thakur, Dilip K Singh, Katherine D Hart, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 12, 1998
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism
M F Paine, M Khalighi, J M Fisher, et al.
Journal of Experimental Pharmacology
|
September 25, 2010
The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation
Ngoc Ngo, Scott J Brantley, Daniel R Carrizosa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 23, 2018
Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (<i>Camellia sinensis)</i> Using a Biochemometric Approach: Application to Raloxifene as a Test Drug via In Vitro to In Vivo Extrapolation
Dan-Dan Tian, Joshua J Kellogg, Neşe Okut, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 31, 2008
Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans
Ngoc Ngo, Zhixia Yan, Tyler N Graf, et al.
Pharmacological Reviews
|
March 13, 2021
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach
Emily J Cox, Dan-Dan Tian, John D Clarke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 2020
A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From Chemical Characterization to Clinical Studies
Caroline Birer-Williams, Brandon T Gufford, Eric Chou, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
March 9, 2019
Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity
John D Clarke, Anika Dzierlenga, Tarana Arman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 4, 2023
An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations
James T Nguyen, Dan-Dan Tian, Rakshit S Tanna, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 175) with videos related to
Sort By:
Page
of 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 22, 2007
Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine
Michael Zhuo Wang, Judy Qiju Wu, Arlene S Bridges, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
From discovery to translation: Endogenous substrates of OAT1 and OAT3 as clinical biomarkers for renal secretory function
Aarzoo Thakur, Dilip K Singh, Katherine D Hart, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 12, 1998
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism
M F Paine, M Khalighi, J M Fisher, et al.
Journal of Experimental Pharmacology
|
September 25, 2010
The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation
Ngoc Ngo, Scott J Brantley, Daniel R Carrizosa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 23, 2018
Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (<i>Camellia sinensis)</i> Using a Biochemometric Approach: Application to Raloxifene as a Test Drug via In Vitro to In Vivo Extrapolation
Dan-Dan Tian, Joshua J Kellogg, Neşe Okut, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 31, 2008
Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans
Ngoc Ngo, Zhixia Yan, Tyler N Graf, et al.
Pharmacological Reviews
|
March 13, 2021
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach
Emily J Cox, Dan-Dan Tian, John D Clarke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 2020
A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From Chemical Characterization to Clinical Studies
Caroline Birer-Williams, Brandon T Gufford, Eric Chou, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
March 9, 2019
Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity
John D Clarke, Anika Dzierlenga, Tarana Arman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 4, 2023
An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations
James T Nguyen, Dan-Dan Tian, Rakshit S Tanna, et al.
Page
of 18